Xcenda Revenue and Competitors
Estimated Revenue & Valuation
- Xcenda's estimated annual revenue is currently $113.8M per year.
- Xcenda's estimated revenue per employee is $201,000
Employee Data
- Xcenda has 566 Employees.
- Xcenda grew their employee count by -23% last year.
Xcenda's People
Name | Title | Email/Phone |
---|---|---|
1 | VP | Reveal Email/Phone |
2 | VP | Reveal Email/Phone |
3 | VP | Reveal Email/Phone |
4 | Chief Platform Architect and Engineer | Reveal Email/Phone |
5 | VP, Market Access Commercialization | Reveal Email/Phone |
6 | VP, Strategic Market Insights | Reveal Email/Phone |
7 | VP, Commercialization Services | Reveal Email/Phone |
8 | VP, Data Intelligence Group | Reveal Email/Phone |
9 | VP Business Development | Reveal Email/Phone |
10 | VP Global Consulting | Reveal Email/Phone |
Xcenda Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $42310M | 169995 | 5% | N/A | $226.6B |
#2 | $31800M | 109578 | 4% | $367M | $146B |
What Is Xcenda?
Xcenda’s story began more than two decades ago when founder Robert Mauch had a revelation: applying health outcomes evidence to clearly prove a therapy's worth and demonstrate its value. It was breakthrough thinking then, and our team carries on that tradition of breaking through barriers today. Dr. Mauch had an equally innovative concept when it came to building a world-class culture. Trust in people’s talents. Create an inclusive environment that energizes and rewards fresh ideas. Give back to your community. Encourage collaboration. And above all else, deliver your best. More than two decades later, Xcenda still applies these core principles in everything we do.
keywords:N/AN/A
Total Funding
566
Number of Employees
$113.8M
Revenue (est)
-23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Xcenda News
According to insights from Xcenda's Managed Care Network, roughly 60% of commercial payers restrict the use of copay assistance through an...
I'm the publisher of Fierce Pharma, and I'm joined today by Corey Ford, Senior Director of Patient Access Strategy at Xcenda and Colleen Cummins,...
As the demand for biosimilar product information continues to grow among payers, Xcenda’s FormularyDecisions—a secure online platform that facilitates information exchange between manufacturers and healthcare decision-makers—announced today the launch of a Biosimilars Hub. The new feature will p ...